All Stories

  1. Identifying patients with acute total coronary occlusion in NSTEACS: finding the high-risk needle in the haystack

    Article • European Heart Journal, August 2017, Oxford University Press (OUP)

    Professor Philippe Gabriel STEG

  2. Viewpoint: a proposal for a simple algorithm for managing oral anticoagulation and antiplatelet therapy in patients with non-valvular atrial fibrillation and coronary stents

    Article • European Heart Journal Acute Cardiovascular Care, September 2016, SAGE Publications

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  3. Editor’s Choice-Medically managed patients with non–ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease

    Article • European Heart Journal Acute Cardiovascular Care, January 2016, SAGE Publications

    Professor Philippe Gabriel STEG

  4. Patient education after acute myocardial infarction

    Article • Journal of Cardiovascular Medicine, November 2015, Wolters Kluwer Health

    Professor Philippe Gabriel STEG

  5. Antiplatelet and anticoagulation agents in acute coronary syndromes: What is the current status and what does the future hold?

    Article • American Heart Journal, November 2014, Elsevier

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli

  6. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry

    Article • International Journal of Cardiology, September 2014, Elsevier

    Professor Philippe Gabriel STEG

  7. Complexity of atrial fibrillation patients and management in Chinese ethnicity in routine daily practice: Insights from the RealiseAF Taiwanese cohort

    Article • Journal of Cardiology, September 2014, Elsevier

    Professor Philippe Gabriel STEG

  8. No misrepresentation of vital status follow-up in PLATO: Predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial

    Article • International Journal of Cardiology, September 2014, Elsevier

    Professor Philippe Gabriel STEG

  9. Outcomes of a Pharmacoinvasive Strategy for Successful Versus Failed Fibrinolysis and Primary Percutaneous Intervention in Acute Myocardial Infarction (from the Strategic Reperfusion Early After Myocardial Infarction [STREAM] Study)

    Article • The American Journal of Cardiology, September 2014, Elsevier

    Professor Philippe Gabriel STEG

  10. Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

    Article • American Heart Journal, July 2014, Elsevier

    Professor Philippe Gabriel STEG

  11. Beta-Blockers in Asymptomatic Coronary Artery Disease

    Article • Journal of the American College of Cardiology, July 2014, Elsevier

    Professor Philippe Gabriel STEG

  12. Impact of Living and Socioeconomic Characteristics on Cardiovascular Risk in Ischemic Stroke Patients

    Article • International Journal of Stroke, June 2014, SAGE Publications

    Professor Philippe Gabriel STEG

  13. Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction

    Article • International Journal of Cardiology, June 2014, Elsevier

    Professor Philippe Gabriel STEG

  14. Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

    Article • Journal of the American College of Cardiology, May 2014, Elsevier

    Professor Philippe Gabriel STEG

  15. Bivalirudin in percutaneous coronary intervention: The EUROpean BiValIrudin UtiliSatION in Practice (EUROVISION) Registry

    Article • International Journal of Cardiology, May 2014, Elsevier

    Professor Philippe Gabriel STEG

  16. Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin–Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial

    Article • American Heart Journal, April 2014, Elsevier

    Professor Philippe Gabriel STEG

  17. ANGIOPOIETIN-LIKE 4 SERUM LEVELS ON ADMISSION FOR ACUTE MYOCARDIAL INFARCTION ARE ASSOCIATED WITH NO-REFLOW ASSESSED BY MAGNETIC RESONANCE IMAGING

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Philippe Gabriel STEG

  18. CARDIOVASCULAR EVENT RATES IN PATIENTS WITH DIABETES: INSIGHTS FROM THE INTERNATIONAL REACH REGISTRY

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  19. PROGNOSTIC IMPLICATIONS OF SIMULTANEOUS BIOMARKER ASSESSMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: OBSERVATIONS FROM THE SAVOR-TIMI 53 TRIAL

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Philippe Gabriel STEG

  20. BIOMARKERS FOR PREDICTION OF OUTCOMES IN REVASCULARIZED PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME: A PLATO SUBSTUDY

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Philippe Gabriel STEG

  21. 0402: Angiopoietin-like 4 serum levels on admission for acute myocardial infarction are associated with no-reflow

    Article • Archives of Cardiovascular Diseases Supplements, April 2014, Elsevier

    Professor Philippe Gabriel STEG

  22. Frequency of the Use of Low- Versus High-Dose Aspirin in Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (from the Dual Antiplatelet Therapy Study)

    Article • The American Journal of Cardiology, April 2014, Elsevier

    Professor Philippe Gabriel STEG

  23. AORTIC INTRAMURAL HEMATOMA: PREDICTORS AND OUTCOMES OF PROGRESSION TO DISSECTION

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Philippe Gabriel STEG

  24. REDUCED DEATH, MYOCARDIAL INFARCTION, AND EARLY STENT THROMBOSIS WITH CANGRELOR VERSUS CLOPIDOGREL ON A BACKGROUND OF BIVALIRUDIN: INSIGHTS FROM CHAMPION PHOENIX

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Philippe Gabriel STEG

  25. TICAGRELOR PLASMA LEVELS BUT NOT CLINICAL OUTCOMES ARE ASSOCIATED WITH TRANSPORTER AND METABOLISM ENZYME GENETIC POLYMORPHISMS

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Philippe Gabriel STEG

  26. BIVALIRUDIN VERSUS HEPARIN WITH OR WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN STEMI PATIENTS UNDERGOING PRIMARY PCI: A POOLED ANALYSIS OF PATIENT-LEVEL DATA FROM THE HORIZONS-AMI AND EUROMAX TRIALS

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Professor Philippe Gabriel STEG

  27. Design and rationale of the TOTAL trial: A randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCI

    Article • American Heart Journal, March 2014, Elsevier

    Professor Philippe Gabriel STEG, Dr Sanjit S Jolly

  28. Procedural Volume and Outcomes With Radial or Femoral Access for Coronary Angiography and Intervention

    Article • Journal of the American College of Cardiology, March 2014, Elsevier

    Professor Philippe Gabriel STEG

  29. Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: Insights from the International RealiseAF Survey

    Article • Archives of Cardiovascular Diseases, February 2014, Elsevier

    Professor Philippe Gabriel STEG

  30. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score

    Article • BMJ Open, February 2014, BMJ

    Professor Philippe Gabriel STEG

  31. Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention

    Article • Journal of the American College of Cardiology, February 2014, Elsevier

    Professor Philippe Gabriel STEG

  32. Clinical Characteristics, Management, and Control of Permanent vs. Nonpermanent Atrial Fibrillation: Insights from the RealiseAF Survey

    Article • PLoS ONE, January 2014, PLOS

    Professor Philippe Gabriel STEG

  33. An Education Program for Risk Factor Management After an Acute Coronary Syndrome

    Article • JAMA Internal Medicine, January 2014, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  34. Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry

    Article • International Journal of Cardiology, January 2014, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  35. NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease

    Article • The American Journal of Medicine, January 2014, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  36. Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome

    Article • International Journal of Cardiology, January 2014, Elsevier

    Professor Philippe Gabriel STEG

  37. Bivalirudin Started during Emergency Transport for Primary PCI

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2013, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG

  38. Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): An international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myoc...

    Article • American Heart Journal, December 2013, Elsevier

    Professor Philippe Gabriel STEG

  39. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data

    Article • The Lancet, December 2013, Elsevier

    Professor Philippe Gabriel STEG

  40. The Impact of Lost Therapeutic Benefit (LTB) in High‐Risk Hypertensive Patients: 2‐Year Follow‐Up Data from the Australian REACH Registry

    Article • Cardiovascular Therapeutics, November 2013, Wiley

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  41. Aortic arch atheroma in transient ischemic attack patients

    Article • Atherosclerosis, November 2013, Elsevier

    Professor Philippe Gabriel STEG

  42. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

    Article • The Lancet, November 2013, Elsevier

    Professor Philippe Gabriel STEG

  43. Predictors of Long‐term Adherence to Evidence‐based Cardiovascular Disease Medications in Outpatients With Stable Atherothrombotic Disease: Findings From the REACH Registry

    Article • Clinical Cardiology, October 2013, Wiley

    Professor Philippe Gabriel STEG

  44. Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

    Article • Platelets, October 2013, Taylor & Francis

    Professor Philippe Gabriel STEG

  45. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2013, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG

  46. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of iva...

    Article • American Heart Journal, October 2013, Elsevier

    Professor Philippe Gabriel STEG

  47. Prognostic significance of presenting blood pressure in non–ST-segment elevation acute coronary syndrome in relation to prior history of hypertension

    Article • American Heart Journal, October 2013, Elsevier

    Professor Philippe Gabriel STEG

  48. TCT-10 Differences Between US and non-US Cohorts after PCI and Dual Antiplatelet Therapy: Patient Characteristics, Randomization

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Professor Philippe Gabriel STEG

  49. Comparison of Bivalirudin Versus Heparin(s) During Percutaneous Coronary Interventions in Patients Receiving Prasugrel: A Propensity‐Matched Study

    Article • Clinical Cardiology, October 2013, Wiley

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli, Dr laurent bonello

  50. Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes

    Article • JAMA, September 2013, American Medical Association (AMA)

    Professor Philippe Gabriel STEG, Professor Antonis S Manolis

  51. Heart Failure in Patients With Atrial Fibrillation Is Associated With a High Symptom and Hospitalization Burden: The RealiseAF Survey

    Article • Clinical Cardiology, September 2013, Wiley

    Professor Philippe Gabriel STEG

  52. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor Philippe Gabriel STEG

  53. Outcomes and Excess Costs among Patients with Cardiovascular Disease

    Article • Heart Lung and Circulation, September 2013, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  54. Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non–ST-segment elevation acute coronary syndromes

    Article • American Heart Journal, August 2013, Elsevier

    Professor Philippe Gabriel STEG

  55. Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis

    Article • The American Journal of Medicine, August 2013, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  56. Thiazolidinedione use is not associated with worse cardiovascular outcomes: A study in 28,332 high risk patients with diabetes in routine clinical practice

    Article • International Journal of Cardiology, August 2013, Elsevier

    Professor Philippe Gabriel STEG

  57. Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)

    Article • JACC Cardiovascular Interventions, July 2013, Elsevier

    Professor Philippe Gabriel STEG, Cafer Zorkun

  58. Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study

    Article • International Journal of Cardiology, June 2013, Elsevier

    Professor Philippe Gabriel STEG

  59. Comparison of Hospital Mortality During ST-Segment Elevation Myocardial Infarction in the Era of Reperfusion Therapy in Women Versus Men and in Older Versus Younger Patients

    Article • The American Journal of Cardiology, June 2013, Elsevier

    Professor Philippe Gabriel STEG

  60. Cardiac diffusion‐weighted MR imaging in recent, subacute, and chronic myocardial infarction: A pilot study

    Article • Journal of Magnetic Resonance Imaging, April 2013, Wiley

    Professor Philippe Gabriel STEG

  61. Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2013, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG

  62. Oxygen therapy in acute coronary syndrome: are the benefits worth the risk?

    Article • European Heart Journal, April 2013, European Society of Cardiology

    Professor Philippe Gabriel STEG

  63. Radial versus femoral access, bleeding and ischemic events in patients with non–ST-segment elevation acute coronary syndrome managed with an invasive strategy

    Article • American Heart Journal, April 2013, Elsevier

    Professor Philippe Gabriel STEG

  64. PREDICTORS OF DUAL ANTIPLATELET THERAPY NON-ADHERENCE AFTER PCI: ONE-YEAR INSIGHTS FROM THE PARIS REGISTRY

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Philippe Gabriel STEG

  65. PREDICTORS OF LONG-TERM ADHERENCE TO EVIDENCE-BASED CARDIOVASCULAR DISEASE MEDICATIONS IN OUTPATIENTS WITH ATHEROTHROMBOTIC DISEASE

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  66. MEDICALLY MANAGED PATIENTS WITH NON ST SEGMENT ACUTE CORONARY SYNDROMES HAVE HETEROGENOUS OUTCOMES, BASED ON PERFORMANCE OF ANGIOGRAPHY, EXTENT OF ANGIOGRAPHIC DISEASE AND AGE

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Philippe Gabriel STEG

  67. Effect of Radial Versus Femoral Access on Radiation Dose and the Importance of Procedural Volume

    Article • JACC Cardiovascular Interventions, March 2013, Elsevier

    Professor Philippe Gabriel STEG

  68. Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors

    Article • International Journal of Cardiology, March 2013, Elsevier

    Professor Philippe Gabriel STEG

  69. APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL

    Article • Journal of the American College of Cardiology, March 2013, Elsevier

    Professor Philippe Gabriel STEG

  70. Impact of Loneliness and Living Alone—Reply

    Article • JAMA Internal Medicine, February 2013, American Medical Association (AMA)

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  71. β-Blocker Use for Patients With or at Risk for Coronary Artery Disease—Reply

    Article • JAMA, February 2013, American Medical Association (AMA)

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  72. 262: Use of allopurinol and risk of myocardial infarction: A case-control study

    Article • Archives of Cardiovascular Diseases Supplements, January 2013, Elsevier

    Professor Philippe Gabriel STEG

  73. 016: Evidence of systemic plaque vulnerability in acute coronary syndromes with FDG-positron emission tomography and computed tomographic angiography in the BIOCORE-2 study

    Article • Archives of Cardiovascular Diseases Supplements, January 2013, Elsevier

    Professor Philippe Gabriel STEG

  74. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation

    Article • Revista Española de Cardiología (English Edition), January 2013, Elsevier

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli

  75. Registry to provide contemporary information regarding characteristics, management and outcomes of outpatients with stable coronary artery disease

    Article • December 2012, Springer Science + Business Media

    Professor Philippe Gabriel STEG

  76. Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syn...

    Article • American Heart Journal, December 2012, Elsevier

    Professor Philippe Gabriel STEG

  77. Effects of Radial Versus Femoral Artery Access in Patients With Acute Coronary Syndromes With or Without ST-Segment Elevation

    Article • Journal of the American College of Cardiology, December 2012, Elsevier

    Professor Philippe Gabriel STEG

  78. β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease

    Article • JAMA, October 2012, American Medical Association (AMA)

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  79. Does lay media ranking of hospitals reflect lower mortality in treating acute myocardial infarction?

    Article • Archives of Cardiovascular Diseases, October 2012, Elsevier

    Professor Philippe Gabriel STEG

  80. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

    Article • The Lancet, October 2012, Elsevier

    Professor Philippe Gabriel STEG

  81. TCT-742 Individual and Regional Variations in Dual Antiplatelet Therapy Dose and Duration in a Large, Randomized International Trial Comparing Two Drug-eluting Stents: Results From PROTECT

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Philippe Gabriel STEG

  82. Factors Contributing to the Lower Mortality With Ticagrelor Compared With Clopidogrel in Patients Undergoing Coronary Artery Bypass Surgery

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Professor Philippe Gabriel STEG

  83. Demographics, Socio-Economic Characteristics, and Risk Factor Prevalence in Patients with Non-Cardioembolic Ischaemic Stroke in Low- and Middle-Income Countries: The OPTIC Registry

    Article • International Journal of Stroke, September 2012, SAGE Publications

    Professor Philippe Gabriel STEG

  84. Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

    Article • American Heart Journal, September 2012, Elsevier

    Professor Philippe Gabriel STEG

  85. Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study

    Article • EuroIntervention, August 2012, Europa Digital & Publishing

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli

  86. Living Alone and Cardiovascular Risk in Outpatients at Risk of or With Atherothrombosis

    Article • Archives of Internal Medicine, July 2012, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  87. Statin and Aspirin Therapy for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

    Article • Clinical Cardiology, July 2012, Wiley

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  88. An International Model to Predict Recurrent Cardiovascular Disease

    Article • The American Journal of Medicine, July 2012, Elsevier

    Professor Philippe Gabriel STEG

  89. Atherothrombotic Disease, Traditional Risk Factors, and 4‐Year Mortality in a Latin American Population: The REACH Registry

    Article • Clinical Cardiology, May 2012, Wiley

    Professor Philippe Gabriel STEG, Dr Erwin Chiquete, Professor Deepak L Bhatt

  90. Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease

    Article • PLoS ONE, May 2012, PLOS

    Professor Philippe Gabriel STEG, Luis Gowdak

  91. Management and outcomes following an acute coronary event in patients with chronic heart failure 1999–2007

    Article • European Journal of Heart Failure, May 2012, Wiley

    Professor Philippe Gabriel STEG

  92. Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial

    Article • American Heart Journal, May 2012, Elsevier

    Professor Philippe Gabriel STEG

  93. Fate of individuals with ischemic amputations in the REACH Registry: Three-year cardiovascular and limb-related outcomes

    Article • Atherosclerosis, April 2012, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  94. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: Results from long-term follow-up of the Occluded Artery Trial (OAT) cohort

    Article • American Heart Journal, April 2012, Elsevier

    Professor Philippe Gabriel STEG

  95. Recurrent acute coronary syndromes are associated with increased shear induced platelet aggregation. A case–control study

    Article • International Journal of Cardiology, March 2012, Elsevier

    Professor Philippe Gabriel STEG

  96. LONG-TERM RISK AND PROGNOSIS OF RECURRENT CARDIOVASCULAR EVENTS IN THE REACH REGISTRY

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  97. GREATER EFFICACY OF TICAGRELOR COMPARED TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME IS NOT DRIVEN BY OUTCOMES IN POOR METABOLIZERS OF CLOPIDOGREL

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Philippe Gabriel STEG

  98. CONSISTENT BENEFIT OF TICAGRELOR COMPARED TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS REGARDLESS OF BASELINE INFLAMMATORY MARKERS

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Philippe Gabriel STEG

  99. METABOLIC SYNDROME, DIABETES MELLITUS, OR BOTH AND CARDIOVASCULAR RISK IN OUTPATIENTS AT RISK OF OR WITH ATHEROTHROMBOSIS IN THE REACH REGISTRY

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  100. RESISTANT HYPERTENSION: A FREQUENT AND OMINOUS FINDING AMONG HYPERTENSIVE PATIENTS WITH ATHEROTHROMBOSIS

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  101. GENDER DIFFERENCES IN CARDIOVASCULAR RISK IN DIABETIC AND NON-DIABETIC OUTPATIENTS AT RISK OF OR WITH ATHEROTHROMBOSIS IN THE REACH REGISTRY

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  102. Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: Analysis of the Occluded Artery Trial (OAT)

    Article • American Heart Journal, March 2012, Elsevier

    Professor Philippe Gabriel STEG

  103. Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis

    Article • The Medical Journal of Australia, February 2012, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  104. Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: Implications on optimisation of timing of treatment from the CARESS-in-AMI trial

    Article • International Journal of Cardiology, February 2012, Elsevier

    Professor Philippe Gabriel STEG, Konstantinos Dimopoulos

  105. Editorial

    Article • Archives of Cardiovascular Diseases Supplements, January 2012, Elsevier

    Professor Philippe Gabriel STEG

  106. Editorial

    Article • Archives of Cardiovascular Diseases Supplements, January 2012, Elsevier

    Professor Philippe Gabriel STEG

  107. Comparison of Acute Coronary Syndrome in Patients Receiving Versus Not Receiving Chronic Dialysis (from the Global Registry of Acute Coronary Events [GRACE] Registry)

    Article • The American Journal of Cardiology, January 2012, Elsevier

    Professor Philippe Gabriel STEG

  108. 023 HIV-infected status is associated with increased recurrence of acute coronary syndrome. Results of long term follow up of the PACS-HIV study

    Article • Archives of Cardiovascular Diseases Supplements, January 2012, Elsevier

    Professor Philippe Gabriel STEG

  109. 225 Symptoms, functional status, and quality of life in patients with controlled and uncontrolled atrial fibrillation. Data from the cross-sectional REALISE-AF registry

    Article • Archives of Cardiovascular Diseases Supplements, January 2012, Elsevier

    Professor Philippe Gabriel STEG

  110. The Association Between Prior Use of Aspirin and/or Warfarin and the In-hospital Management and Outcomes in Patients Presenting With Acute Coronary Syndromes: Insights From the Global Registry of Acute Coronary Events (GRACE)

    Article • Canadian Journal of Cardiology, January 2012, Elsevier

    Professor Philippe Gabriel STEG

  111. Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)

    Article • The American Journal of Cardiology, December 2011, Elsevier

    Professor Philippe Gabriel STEG

  112. The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study

    Article • American Heart Journal, November 2011, Elsevier

    Professor Philippe Gabriel STEG

  113. Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes

    Article • Canadian Journal of Cardiology, November 2011, Elsevier

    Professor Philippe Gabriel STEG

  114. Ethnic Differences in Cardiovascular Risks and Mortality in Atherothrombotic Disease: Insights From the REduction of Atherothrombosis for Continued Health (REACH) Registry

    Article • Mayo Clinic Proceedings, October 2011, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  115. Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH Registry

    Article • Clinical Therapeutics, October 2011, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  116. Study design and rationale for the Stabilization of pLaques usIng Darapladib—Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome

    Article • American Heart Journal, October 2011, Elsevier

    Professor Philippe Gabriel STEG

  117. Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention

    Article • International Journal of Cardiology, July 2011, Elsevier

    Professor Philippe Gabriel STEG

  118. Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

    Article • American Heart Journal, July 2011, Elsevier

    Professor Philippe Gabriel STEG

  119. A simple nomogram for early prediction of myocardial reperfusion after pre-hospital thrombolysis

    Article • EuroIntervention, June 2011, Europa Digital & Publishing

    Professor Philippe Gabriel STEG

  120. Impact of transradial and transfemoral coronary interventions on bleeding and net adverse clinical events in acute coronary syndromes

    Article • EuroIntervention, May 2011, Europa Digital & Publishing

    Professor Philippe Gabriel STEG

  121. The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial

    Article • Journal of the American College of Cardiology, May 2011, Elsevier

    Professor Philippe Gabriel STEG

  122. Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non–ST-elevation acute coronary syndromes

    Article • American Heart Journal, May 2011, Elsevier

    Professor Philippe Gabriel STEG

  123. Delphi-Consensus Weights for Ischemic and Bleeding Events to Be Included in a Composite Outcome for RCTs in Thrombosis Prevention

    Article • PLoS ONE, April 2011, PLOS

    Professor Philippe Gabriel STEG

  124. REAL LIFE USE OF ANTITHROMBOTIC TREATMENT IN ATRIAL FIBRILLATION: INSIGHTS FROM THE INTERNATIONAL REALISEAF REGISTRY

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Philippe Gabriel STEG

  125. ANGIOGRAPHIC OUTCOMES IN THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Philippe Gabriel STEG, Cafer Zorkun

  126. CYSTATIN C IS AN INDEPENDENT RISK PREDICTOR FOR DEATH OR MYOCARDIAL INFARCTION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) AS WELL AS IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME (NSTE-ACS)

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Philippe Gabriel STEG

  127. EVALUATION OF THE EFFICACY AND SAFETY OF OTAMIXABAN VS. UNFRACTIONATED HEPARIN+EPTIFIBATIDE IN ELDERLY PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES IN THE SEPIA-ACS1 TIMI 42 TRIAL

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Philippe Gabriel STEG

  128. RELATIONSHIP BETWEEN BLEEDING AND MORTALITY IN PATIENTS ON DUAL ANTIPLATELET THERAPY VS ASPIRIN ALONE: RESULTS FROM THE CHARISMA TRIAL

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Philippe Gabriel STEG

  129. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial

    Article • The Lancet, April 2011, Elsevier

    Professor Philippe Gabriel STEG

  130. Outcomes from patients with multi‐vessel disease following primary PCI

    Article • Catheterization and Cardiovascular Interventions, March 2011, Wiley

    Professor Philippe Gabriel STEG

  131. Safety of Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction (from the BEAUTIFUL Holter Substudy)

    Article • The American Journal of Cardiology, March 2011, Elsevier

    Professor Philippe Gabriel STEG

  132. Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-...

    Article • American Heart Journal, March 2011, Elsevier

    Professor Philippe Gabriel STEG

  133. The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST

    Article • American Heart Journal, February 2011, Elsevier

    Professor Philippe Gabriel STEG

  134. Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention

    Article • JACC Cardiovascular Interventions, February 2011, Elsevier

    Professor Philippe Gabriel STEG, Professor Marco Valgimigli

  135. Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes

    Article • American Heart Journal, February 2011, Elsevier

    Professor Philippe Gabriel STEG

  136. Myocardial infarction after blunt chest trauma: usefulness of cardiac ECG-gated CT and MRI for positive and aetiologic diagnosis

    Article • Emergency Radiology, January 2011, Springer Science + Business Media

    Professor Philippe Gabriel STEG

  137. Editorial

    Article • Archives of Cardiovascular Diseases Supplements, January 2011, Elsevier

    Professor Philippe Gabriel STEG

  138. Editorial

    Article • Archives of Cardiovascular Diseases Supplements, January 2011, Elsevier

    Professor Philippe Gabriel STEG

  139. 126 Speckle tracking echocardiography as a potential diagnostic method for acute myocarditis: A pilot comparaison to cardiac MRI

    Article • Archives of Cardiovascular Diseases Supplements, January 2011, Elsevier

    Professor Philippe Gabriel STEG

  140. Results from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

    Article • January 2011, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  141. Two-Year Vascular Event Rates in Patients with Symptomatic Cerebrovascular Disease: The REACH Registry

    Article • Cerebrovascular Diseases, January 2011, Karger Publishers

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  142. 229 Screening for abdominal aortic aneurysm among patients admitted for acute myocardial infarction using portable transthoracic echocardiography

    Article • Archives of Cardiovascular Diseases Supplements, January 2011, Elsevier

    Professor Philippe Gabriel STEG

  143. 012 Acute coronary syndrome in HIV-infected patients: characteristics and prognosis

    Article • Archives of Cardiovascular Diseases Supplements, January 2011, Elsevier

    Professor Philippe Gabriel STEG

  144. 240 Pre-hospital abciximab initiation in STEMI. MISTRAL: a prospective controlled randomized double blinded trial

    Article • Archives of Cardiovascular Diseases Supplements, January 2011, Elsevier

    Professor Philippe Gabriel STEG

  145. Cardiovascular risk profiles and outcomes of Chinese living inside and outside China

    Article • European Journal of Cardiovascular Prevention & Rehabilitation, December 2010, Oxford University Press (OUP)

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  146. Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation...

    Article • American Heart Journal, December 2010, Elsevier

    Professor Philippe Gabriel STEG

  147. Can an elderly woman's heart be too strong?

    Article • American Heart Journal, November 2010, Elsevier

    Professor Philippe Gabriel STEG

  148. Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events

    Article • American Heart Journal, November 2010, Elsevier

    Professor Philippe Gabriel STEG

  149. Recurrent ischemia across the spectrum of acute coronary syndromes: Prevalence and prognostic significance of (Re-)infarction and ST-segment changes in a large contemporary registry

    Article • International Journal of Cardiology, November 2010, Elsevier

    Professor Philippe Gabriel STEG

  150. PCV121 A SURVEY OF PHYSICIANS' ATTITUDES TOWARD THE CONTROL OF CARDIOVASCULAR RISK FACTORS. THE EURIKA STUDY.

    Article • Value in Health, November 2010, Elsevier

    Professor Philippe Gabriel STEG

  151. PCV30 PREVALENCE AND CONTROL OF TRADITIONAL CARDIOVASCULAR RISK FACTORS AND ANTICIPATED AVOIDABLE CORONARY MORTALITY IN PRIMARY PREVENTION IN EUROPE:THE EURIKA STUDY

    Article • Value in Health, November 2010, Elsevier

    Professor Philippe Gabriel STEG

  152. CV1 USING REAL WORLD DATA TO CALCULATE THE COST-EFFECTIVENESS OF STATIN AMONG PARTICIPNATS WITH ATHEROTHROMBOTIC DISEASE IN AUSTRALIAN GENERAL PRACTICE

    Article • Value in Health, November 2010, Elsevier

    Professor Philippe Gabriel STEG

  153. Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI

    Article • JAMA, October 2010, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  154. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis

    Article • European Heart Journal, October 2010, European Society of Cardiology

    Professor Philippe Gabriel STEG

  155. One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry

    Article • Canadian Journal of Cardiology, October 2010, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  156. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

    Article • The Lancet, October 2010, Elsevier

    Professor Philippe Gabriel STEG

  157. Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

    Article • American Heart Journal, October 2010, Elsevier

    Professor Philippe Gabriel STEG

  158. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

    Article • The Lancet, October 2010, Elsevier

    Professor Philippe Gabriel STEG

  159. Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis

    Article • JAMA, September 2010, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  160. Prior Cardiovascular Interventions Are Not Associated With Worsened Clinical Outcomes in Patients With Symptomatic Atherothrombosis

    Article • Critical Pathways in Cardiology A Journal of Evidence-Based Medicine, September 2010, Wolters Kluwer Health

    Professor Philippe Gabriel STEG

  161. Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial

    Article • The Lancet, August 2010, Elsevier

    Professor Philippe Gabriel STEG, Professor Dmitry Zateyshchikov

  162. Assessment of Atherothrombosis and Its Treatment in Mexico: First‐Year Data of the REACH Registry

    Article • Clinical Cardiology, July 2010, Wiley

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  163. Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA)

    Article • BMC Public Health, June 2010, Springer Science + Business Media

    Professor Philippe Gabriel STEG

  164. Adjunctive Pharmacologic Therapies

    Article • May 2010, Taylor & Francis

    Professor Philippe Gabriel STEG

  165. Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance project

    Article • Archives of Cardiovascular Diseases, April 2010, Elsevier

    Professor Philippe Gabriel STEG

  166. Predictors of Annual Pharmaceutical Costs in Australia for Community-Based Individuals with, or at Risk of, Cardiovascular Disease

    Article • American Journal of Cardiovascular Drugs, April 2010, Springer Science + Business Media

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  167. INTERACTION BETWEEN TIME TO TREATMENT AND TYPE OF REPERFUSION THERAPY IN STEMI: A POOLED ANALYSIS OF ONE-YEAR MORTALITY IN THE COMPARISON OF ANGIOPLASTY & PREHOSPITAL THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION (CAPTIM) AND WHICH EARLY ST-ELEVATION...

    Article • Journal of the American College of Cardiology, March 2010, Elsevier

    Professor Philippe Gabriel STEG

  168. Ethnic differences in the relationships of anthropometric measures to metabolic risk factors in Asian patients at risk of atherothrombosis

    Article • Metabolism, March 2010, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt, Professor Tzung-Dau Wang

  169. Cardiovascular Event Rates in Diabetic and Nondiabetic Individuals With and Without Established Atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)

    Article • The American Journal of Cardiology, March 2010, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  170. THE INCIDENCE OF ARRHYTHMIAS AND CLINICAL ARRHYTHMIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED WITH TICAGRELOR OR CLOPIDOGREL IN THE PLATO TRIAL

    Article • Journal of the American College of Cardiology, March 2010, Elsevier

    Professor Philippe Gabriel STEG

  171. TICAGRELOR DOES NOT AFFECT PULMONARY FUNCTION TESTS COMPARED TO CLOPIDOGREL IN ACUTE CORONARY SYNDROMES: RESULTS OF THE PLATO PULMONARY SUBSTUDY

    Article • Journal of the American College of Cardiology, March 2010, Elsevier

    Professor Philippe Gabriel STEG

  172. Statins in the elderly: What evidence of their benefit in prevention?

    Article • Archives of Cardiovascular Diseases, February 2010, Elsevier

    Professor Philippe Gabriel STEG

  173. Current Use of Aspirin and Antithrombotic Agents in the United States Among Outpatients With Atherothrombotic Disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)

    Article • The American Journal of Cardiology, February 2010, Elsevier

    Professor Philippe Gabriel STEG

  174. Editorial

    Article • Archives of Cardiovascular Diseases Supplements, January 2010, Elsevier

    Professor Philippe Gabriel STEG

  175. Editorial

    Article • Archives of Cardiovascular Diseases Supplements, January 2010, Elsevier

    Professor Philippe Gabriel STEG

  176. The economic implications of treating atherothrombotic disease in australia, from the government perspective

    Article • Clinical Therapeutics, January 2010, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  177. 014 Risk score to predict serious bleeding in stable outpatients with atherothrombosis

    Article • Archives of Cardiovascular Diseases Supplements, January 2010, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  178. Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial

    Article • American Heart Journal, January 2010, Elsevier

    Professor Philippe Gabriel STEG

  179. 008 Circulating secreted phospholipase A2 activity: an early prognostic marker in unselected patients presenting to the emergency department with suspected acute coronary syndrome

    Article • Archives of Cardiovascular Diseases Supplements, January 2010, Elsevier

    Professor Philippe Gabriel STEG

  180. 015 The CHADS2 score predicts more accurately adverse cardiovascular outcome in atherothrombotic patients without atrial fibrillation than established scores: Insights from the European REACH registry

    Article • Archives of Cardiovascular Diseases Supplements, January 2010, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  181. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

    Article • The Lancet, January 2010, Elsevier

    Professor Philippe Gabriel STEG

  182. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: Results from 1-year outcomes in the Japanese REACH Registry

    Article • Journal of the Neurological Sciences, December 2009, Elsevier

    Professor Philippe Gabriel STEG

  183. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

    Article • American Heart Journal, December 2009, Elsevier

    Professor Philippe Gabriel STEG

  184. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience

    Article • American Heart Journal, December 2009, Elsevier

    Professor Philippe Gabriel STEG

  185. Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group

    Article • American Heart Journal, December 2009, Elsevier

    Professor Philippe Gabriel STEG

  186. Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent imp...

    Article • American Heart Journal, December 2009, Elsevier

    Professor Philippe Gabriel STEG

  187. Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT)

    Article • EuroIntervention, November 2009, Europa Digital & Publishing

    Professor Philippe Gabriel STEG

  188. Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention

    Article • JACC Cardiovascular Interventions, November 2009, Elsevier

    Professor Philippe Gabriel STEG

  189. Lowering mortality in ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: key prehospital and emergency room treatment strategies

    Article • European Journal of Emergency Medicine, October 2009, Wolters Kluwer Health

    Professor Philippe Gabriel STEG

  190. Impact of Systemic Hypertension on the Diagnostic Performance of B-Type Natriuretic Peptide in Patients With Acute Dyspnea

    Article • The American Journal of Cardiology, October 2009, Elsevier

    Professor Philippe Gabriel STEG

  191. The authors' reply:

    Article • Heart, September 2009, BMJ

    Professor Philippe Gabriel STEG

  192. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2009, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG, Professor Antonis S Manolis, Professor Dmitry Zateyshchikov, Massimo Volpe

  193. Immediate vs Delayed Intervention for Acute Coronary Syndromes

    Article • JAMA, September 2009, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  194. Antithrombotics in Acute Coronary Syndromes

    Article • Journal of the American College of Cardiology, September 2009, Elsevier

    Professor Philippe Gabriel STEG

  195. Regional and Practice Variation in Adherence to Guideline Recommendations for Secondary and Primary Prevention Among Outpatients With Atherothrombosis or Risk Factors in the United States

    Article • Critical Pathways in Cardiology A Journal of Evidence-Based Medicine, September 2009, Wolters Kluwer Health

    Professor Philippe Gabriel STEG

  196. Drug Treatment and Cost of Cardiovascular Disease in Australia

    Article • Cardiovascular Therapeutics, August 2009, Wiley

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  197. The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention

    Article • Journal of the American College of Cardiology, August 2009, Elsevier

    Professor Philippe Gabriel STEG

  198. Renal function, atherothrombosis extent, and outcomes in high-risk patients

    Article • American Heart Journal, July 2009, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  199. Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines

    Article • Journal of the American College of Cardiology, July 2009, Elsevier

    Professor Philippe Gabriel STEG

  200. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial

    Article • Archives of Cardiovascular Diseases, June 2009, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  201. Introducción

    Article • Medicina Clínica, June 2009, Elsevier

    Professor Philippe Gabriel STEG, MD, PhD Aleix Cases

  202. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry

    Article • Atherosclerosis, June 2009, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt, Director of the stroke unit, DMSci, clinical research associate professor Helle K. Iversen

  203. Validity of a risk-prediction tool for hospital mortality: The Global Registry of Acute Coronary Events

    Article • American Heart Journal, June 2009, Elsevier

    Professor Philippe Gabriel STEG

  204. Cardiovascular Ischemic Event Rates in Outpatients With Symptomatic Atherothrombosis or Risk Factors in the United States

    Article • Critical Pathways in Cardiology A Journal of Evidence-Based Medicine, June 2009, Wolters Kluwer Health

    Professor Philippe Gabriel STEG

  205. Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2009, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG

  206. Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention

    Article • Trials, May 2009, Springer Science + Business Media

    Professor Philippe Gabriel STEG

  207. T1970 Risk Factors for Digestive Complications in Cardiology Outpatients Treated Chronically with Antiplatelet Agents

    Article • Gastroenterology, May 2009, Elsevier

    Professor Philippe Gabriel STEG

  208. Retinal microvascularisation abnormalities and cardiovascular risk

    Article • Archives of Cardiovascular Diseases, May 2009, Elsevier

    Professor Philippe Gabriel STEG

  209. Response to “Atrial fibrillation and atherothrombosis: The importance of anticoagulation” by Escobar C and Barrios V

    Article • American Heart Journal, May 2009, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  210. Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial

    Article • American Heart Journal, May 2009, Elsevier

    Professor Philippe Gabriel STEG

  211. Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] ...

    Article • The American Journal of Cardiology, May 2009, Elsevier

    Professor Philippe Gabriel STEG

  212. Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary intervention

    Article • BMC Medical Research Methodology, April 2009, Springer Science + Business Media

    Professor Philippe Gabriel STEG

  213. Unconventional End Points in Cardiovascular Clinical Trials: Should We Be Moving Away From Morbidity and Mortality?

    Article • Journal of Cardiac Failure, April 2009, Elsevier

    Professor Philippe Gabriel STEG, Professor John GF Cleland

  214. Universal reperfusion therapy can be implemented: Lessons from 20 years of management of patients admitted within 6 hours of symptom onset with ST-segment elevation acute myocardial infarction

    Article • Archives of Cardiovascular Diseases, April 2009, Elsevier

    Professor Philippe Gabriel STEG

  215. Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

    Article • American Heart Journal, April 2009, Elsevier

    Professor Philippe Gabriel STEG

  216. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction

    Article • Thrombosis and Haemostasis, March 2009, Schattauer GmbH

    Professor Philippe Gabriel STEG

  217. Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE])

    Article • The American Journal of Cardiology, March 2009, Elsevier

    Professor Philippe Gabriel STEG

  218. ESC Guidelines on Management of Acute Myocardial Infarction in Patients Presenting With Persistent ST-Segment Elevation

    Article • Revista Española de Cardiología (English Edition), March 2009, Elsevier

    Professor Philippe Gabriel STEG

  219. Risk Stratification in Non-ST-segment Elevation Acute Coronary Syndromes: Troponin Alone Is not Enough

    Article • The American Journal of Medicine, February 2009, Elsevier

    Professor Philippe Gabriel STEG

  220. Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest

    Article • American Heart Journal, February 2009, Elsevier

    Professor Philippe Gabriel STEG

  221. Genetic Determinants of Response to Clopidogrel and Cardiovascular Events

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2009, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG

  222. The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: Results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial

    Article • American Heart Journal, January 2009, Elsevier

    Professor Philippe Gabriel STEG

  223. Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE])

    Article • The American Journal of Cardiology, January 2009, Elsevier

    Professor Philippe Gabriel STEG

  224. Ivabradine in heart failure: what about digoxin? – Authors' reply

    Article • The Lancet, December 2008, Elsevier

    Professor Philippe Gabriel STEG

  225. A randomised trial of three counselling strategies for lifestyle changes in patients with hypercholesterolemia treated with ezetimibe on top of statin therapy (TWICE)

    Article • Archives of Cardiovascular Diseases, November 2008, Elsevier

    Professor Philippe Gabriel STEG

  226. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis

    Article • American Heart Journal, November 2008, Elsevier

    Professor Philippe Gabriel STEG

  227. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: Data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

    Article • Journal of Vascular Surgery, October 2008, Elsevier

    Professor Philippe Gabriel STEG

  228. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

    Article • The Lancet, September 2008, Elsevier

    Professor Philippe Gabriel STEG, Professor Antonis S Manolis, Professor Dmitry Zateyshchikov

  229. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

    Article • The Lancet, September 2008, Elsevier

    Professor Philippe Gabriel STEG, Professor Antonis S Manolis

  230. A Meta-Analysis That Misses the Mark

    Article • Journal of the American College of Cardiology, August 2008, Elsevier

    Professor Philippe Gabriel STEG

  231. Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry

    Article • Nature Clinical Practice Neurology, July 2008, Springer Science + Business Media

    Professor Philippe Gabriel STEG

  232. CARESS-in-AMI study – Authors' reply

    Article • The Lancet, June 2008, Elsevier

    Professor Philippe Gabriel STEG

  233. Does PERISCOPE Provide a New Perspective on Diabetic Treatment?

    Article • JAMA, April 2008, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  234. Usefulness of Quantitative Versus Qualitative ST-Segment Depression for Risk Stratification of Non-ST Elevation Acute Coronary Syndromes in Contemporary Clinical Practice

    Article • The American Journal of Cardiology, April 2008, Elsevier

    Professor Philippe Gabriel STEG

  235. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial

    Article • The Lancet, February 2008, Elsevier

    Professor Philippe Gabriel STEG, Konstantinos Dimopoulos

  236. Reply

    Article • Journal of the American College of Cardiology, January 2008, Elsevier

    Professor Philippe Gabriel STEG

  237. Risk Factor Profile and Management of Cerebrovascular Patients in the REACH Registry

    Article • Cerebrovascular Diseases, January 2008, Karger Publishers

    Professor Philippe Gabriel STEG

  238. The paradox of cholesterol and stroke

    Article • The Lancet, December 2007, Elsevier

    Professor Philippe Gabriel STEG

  239. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects

    Article • The Lancet Neurology, November 2007, Elsevier

    Professor Philippe Gabriel STEG

  240. Revascularization Before Noncardiac Surgery: Is There an Impact of Drug-Eluting Stent Thrombosis?

    Article • Journal of the American College of Cardiology, October 2007, Elsevier

    Professor Philippe Gabriel STEG

  241. Resting Heart Rate in Cardiovascular Disease

    Article • Journal of the American College of Cardiology, August 2007, Elsevier

    Professor Philippe Gabriel STEG

  242. Prothrombotic markers and early spontaneous recanalization in st-segment elevation myocardial infarction

    Article • Thrombosis and Haemostasis, July 2007, Schattauer GmbH

    Professor Philippe Gabriel STEG

  243. Relationship of ST elevation in lead aVR with angiographic findings and outcome in non–ST elevation acute coronary syndromes

    Article • American Heart Journal, July 2007, Elsevier

    Professor Philippe Gabriel STEG

  244. Impact of Prior Peripheral Arterial Disease and Stroke on Outcomes of Acute Coronary Syndromes and Effect of Evidence-Based Therapies (from the Global Registry of Acute Coronary Events)

    Article • The American Journal of Cardiology, July 2007, Elsevier

    Professor Philippe Gabriel STEG

  245. Measurement and prevention of myocardial injury during percutaneous coronary intervention

    Article • Heart, June 2007, BMJ

    Professor Philippe Gabriel STEG

  246. Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006

    Article • JAMA, May 2007, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  247. Clinical End Points in Coronary Stent Trials

    Article • Circulation, May 2007, Wolters Kluwer Health

    Professor Philippe Gabriel STEG

  248. Comparisons of Guideline-Recommended Therapies in Patients With Documented Coronary Artery Disease Having Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Versus Medical Therapy Only (from the REACH International Registry)

    Article • The American Journal of Cardiology, May 2007, Elsevier

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  249. Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial

    Article • Journal of the American College of Cardiology, May 2007, Elsevier

    Professor Philippe Gabriel STEG

  250. Does Preventive PCI Work?

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2007, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG

  251. Use of proven therapies in non–ST-elevation acute coronary syndromes according to evidence-based risk stratification

    Article • American Heart Journal, April 2007, Elsevier

    Professor Philippe Gabriel STEG

  252. One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis

    Article • JAMA, March 2007, American Medical Association (AMA)

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  253. A Cause for Concern

    Article • Circulation, March 2007, Wolters Kluwer Health

    Professor Philippe Gabriel STEG

  254. Do the benefits of early invasive therapy for non-STE acute coronary syndromes persist with long-term follow-up?

    Article • Nature Clinical Practice Neurology, February 2007, Springer Science + Business Media

    Professor Philippe Gabriel STEG

  255. External Validity of Clinical Trials in Acute Myocardial Infarction

    Article • Archives of Internal Medicine, January 2007, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  256. Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes

    Article • The American Journal of Medicine, January 2007, Elsevier

    Professor Philippe Gabriel STEG

  257. Prevalence, Awareness and Treatment of Cardiovascular Risk Factors in Patients at High Risk of Atherothrombosis in Japan

    Article • Circulation Journal, January 2007, Japanese Circulation Society

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  258. Coronary Intervention for Persistent Occlusion after Myocardial Infarction

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2006, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG

  259. Ischemia-Modified Albumin in Acute Stroke

    Article • Cerebrovascular Diseases, December 2006, Karger Publishers

    Professor Philippe Gabriel STEG

  260. Patterns of use and potential impact of early β-blocker therapy in non–ST-elevation myocardial infarction with and without heart failure: The Global Registry of Acute Coronary Events

    Article • American Heart Journal, December 2006, Elsevier

    Professor Philippe Gabriel STEG

  261. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in p...

    Article • American Heart Journal, November 2006, Elsevier

    Professor Philippe Gabriel STEG

  262. Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2006, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG

  263. A Randomized Comparison of High Clopidogrel Loading Doses in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

    Article • Journal of the American College of Cardiology, September 2006, Elsevier

    Professor Philippe Gabriel STEG

  264. Predischarge C-Reactive Protein and 1-year Outcome After Acute Coronary Syndromes

    Article • The American Journal of Medicine, August 2006, Elsevier

    Professor Philippe Gabriel STEG

  265. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2006, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG, Professor Thomas Munzel or Muenzel

  266. Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction

    Article • Archives of Internal Medicine, April 2006, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  267. The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design

    Article • American Heart Journal, April 2006, Elsevier

    Professor Philippe Gabriel STEG

  268. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: Lessons from the Global Registry of Acute Coronary Events (GRACE)

    Article • American Heart Journal, March 2006, Elsevier

    Professor Philippe Gabriel STEG

  269. Reply

    Article • The American Journal of Cardiology, January 2006, Elsevier

    Professor Philippe Gabriel STEG

  270. Impact of the History of Congestive Heart Failure on the Utility of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure: Results from the Breathing Not Properly Multinational Study

    Article • The American Journal of Medicine, January 2006, Elsevier

    Professor Philippe Gabriel STEG

  271. Is Primary Angioplasty More Effective Than Prehospital Fibrinolysis in Diabetics With Acute Myocardial Infarction? Data From the CAPTIM Randomized Clinical Trial

    Article • ACC Current Journal Review, December 2005, Elsevier

    Professor Philippe Gabriel STEG

  272. Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes

    Article • Journal of the American College of Cardiology, October 2005, Elsevier

    Professor Philippe Gabriel STEG

  273. Unmet medical needs and therapeutic opportunities in stable angina

    Article • European Heart Journal Supplements, September 2005, Oxford University Press (OUP)

    Professor Philippe Gabriel STEG

  274. A global view of atherothrombosis: Baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

    Article • American Heart Journal, September 2005, Elsevier

    Professor Philippe Gabriel STEG

  275. Medication performance measures and mortality following acute coronary syndromes

    Article • The American Journal of Medicine, August 2005, Elsevier

    Professor Philippe Gabriel STEG

  276. B-Type Natriuretic Peptide and Echocardiographic Determination of Ejection Fraction in the Diagnosis of Congestive Heart Failure in Patients With Acute Dyspnea

    Article • CHEST Journal, July 2005, Elsevier

    Professor Philippe Gabriel STEG

  277. Enhanced Shear-Induced Platelet Aggregation in Patients Who Experience Subacute Stent Thrombosis

    Article • Journal of the American College of Cardiology, June 2005, Elsevier

    Professor Philippe Gabriel STEG

  278. Cigarette smoking and acute coronary syndromes: A multinational observational study

    Article • International Journal of Cardiology, April 2005, Elsevier

    Professor Philippe Gabriel STEG

  279. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting

    Article • The American Journal of Cardiology, February 2005, Elsevier

    Professor Philippe Gabriel STEG

  280. Atherothrombosis and Stroke – A Lot More to Know!

    Article • Cerebrovascular Diseases, January 2005, Karger Publishers

    Professor Philippe Gabriel STEG, Professor Deepak L Bhatt

  281. Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study)

    Article • The American Journal of Cardiology, December 2004, Elsevier

    Professor Philippe Gabriel STEG

  282. Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI)

    Article • American Heart Journal, September 2004, Elsevier

    Professor Philippe Gabriel STEG

  283. Impact of the history of congestive heart failure on accuracy of BNP in the emergency diagnosis of heart failure: results from the breathing not properly (BNP) multinational study

    Article • Journal of Cardiac Failure, August 2004, Elsevier

    Professor Philippe Gabriel STEG

  284. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study

    Article • The American Journal of Medicine, July 2004, Elsevier

    Professor Philippe Gabriel STEG

  285. A Validated Prediction Model for All Forms of Acute Coronary Syndrome

    Article • JAMA, June 2004, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  286. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study

    Article • American Heart Journal, June 2004, Elsevier

    Professor Philippe Gabriel STEG

  287. La définition de la resténose vue par le clinicien : aspects méthodologiques et angiographiques

    Article • Pathologie Biologie, May 2004, Elsevier

    Professor Philippe Gabriel STEG

  288. 815-4 Impact of an open artery late after infarction: Angiographic results of the DECOPI randomized trial

    Article • Journal of the American College of Cardiology, March 2004, Elsevier

    Professor Philippe Gabriel STEG, MD Christophe Thuaire

  289. 859-2 Utility of B-natriuretic peptide levels in predicting outcome of hospitalized patients with congestive heart failure: Results of the breathing not properly (BNP) multinational study

    Article • Journal of the American College of Cardiology, March 2004, Elsevier

    Professor Philippe Gabriel STEG

  290. Syndromes coronariens aigus : un changement de paradigme

    Article • médecine/sciences, February 2004, EDP Sciences

    Professor Philippe Gabriel STEG

  291. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (The Global Registry of Acute Coronary Events [GRACE])

    Article • The American Journal of Cardiology, February 2004, Elsevier

    Professor Philippe Gabriel STEG

  292. Circadian variations in outcome ofprimary percutaneous coronary intervention

    Article • Journal of the American College of Cardiology, December 2003, Elsevier

    Professor Philippe Gabriel STEG

  293. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)

    Article • American Heart Journal, December 2003, Elsevier

    Professor Philippe Gabriel STEG

  294. The impact of age, race and gender on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the breathing not properly (BNP) multinational study

    Article • Journal of Cardiac Failure, October 2003, Elsevier

    Professor Philippe Gabriel STEG

  295. Patterns of use of heparins in ACS

    Article • Thrombosis and Haemostasis, August 2003, Schattauer GmbH

    Professor Philippe Gabriel STEG

  296. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction

    Article • Journal of the American College of Cardiology, June 2003, Elsevier

    Professor Philippe Gabriel STEG

  297. Determinants of use and outcomes of invasive coronary procedures in acute coronary syndromes: results from ENACT

    Article • European Heart Journal, April 2003, European Society of Cardiology

    Professor Philippe Gabriel STEG

  298. Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non–ST-segment elevation acute myocardial infarction (the ARMADA study)

    Article • The American Journal of Cardiology, April 2003, Elsevier

    Professor Philippe Gabriel STEG

  299. A comparison of bedside B-type natriuretic peptide versus echocardiographic determination of ejection fraction in the diagnosis of heart failure

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Professor Philippe Gabriel STEG

  300. Uncovering heart failure in patients with bronchospasm: Rationale for the early use of B-type natriuretic peptide in the emergency department

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Professor Philippe Gabriel STEG

  301. What is in the differential diagnosis of a B-type natriuretic peptide level of 1,000 pg/ml?

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Professor Philippe Gabriel STEG

  302. What causes elevated B-type natriuretic peptide in patients without heart failure?

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Professor Philippe Gabriel STEG

  303. Acute coronary syndrome patients with ST-segment depression have substantial mortality rates but undergo less aggressive management strategies: Insights from the global registry of acute coronary events (GRACE)

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Professor Philippe Gabriel STEG

  304. A robust prediction model for all forms of acute coronary syndromes: Estimating the risk of in-hospital death and myocardial infarction in the global registry of acute coronary events registry

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Professor Philippe Gabriel STEG

  305. Beside B-type natriuretic peptide in the emergency diagnosis of systolic and nonsystolic heart failure: Results from the breathing not properly (BNP) multinational study

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Professor Philippe Gabriel STEG

  306. B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the BNP multinational study

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Professor Philippe Gabriel STEG

  307. Stable Angina

    Article • American Journal of Cardiovascular Drugs, January 2003, Springer Science + Business Media

    Professor Philippe Gabriel STEG

  308. Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab

    Article • The American Journal of Cardiology, December 2002, Elsevier

    Professor Philippe Gabriel STEG

  309. Mortality at 1 Year With Combination Platelet Glycoprotein IIb/IIIa Inhibition and Reduced-Dose Fibrinolytic Therapy vs Conventional Fibrinolytic Therapy for Acute Myocardial Infarction

    Article • JAMA, November 2002, American Medical Association (AMA)

    Professor Philippe Gabriel STEG

  310. Low–molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus*

    Article • American Heart Journal, October 2002, Elsevier

    Professor Philippe Gabriel STEG

  311. Is direct coronary stenting the best strategy for long-term outcome? Results of the multicentric randomized benefit evaluation of direct coronary stenting (BET) study

    Article • American Heart Journal, October 2002, Elsevier

    Professor Philippe Gabriel STEG

  312. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study

    Article • The Lancet, September 2002, Elsevier

    Professor Philippe Gabriel STEG

  313. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)**Further information about the project, along with a complete list o...

    Article • The American Journal of Cardiology, August 2002, Elsevier

    Professor Philippe Gabriel STEG

  314. Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry)

    Article • The American Journal of Cardiology, April 2002, Elsevier

    Professor Philippe Gabriel STEG

  315. Determinants and outcomes of congestive heart failure complicating acute coronary syndromes: observations from the global registry of acute coronary events

    Article • Journal of the American College of Cardiology, March 2002, Elsevier

    Professor Philippe Gabriel STEG

  316. Improved outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery treated with combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition

    Article • Journal of the American College of Cardiology, March 2002, Elsevier

    Professor Philippe Gabriel STEG

  317. The independent contribution to elevations in B-type natriuretic peptide from atrial fibrillation

    Article • Journal of the American College of Cardiology, March 2002, Elsevier

    Professor Philippe Gabriel STEG

  318. B-type natriuretic peptide in the emergency diagnosis of diastolic dysfunction heart failure

    Article • Journal of the American College of Cardiology, March 2002, Elsevier

    Professor Philippe Gabriel STEG

  319. The effect of diabetes on B-type natriuretic peptide levels in patients with acute dyspnea

    Article • Journal of the American College of Cardiology, March 2002, Elsevier

    Professor Philippe Gabriel STEG

  320. B-type natriuretic peptide adds to clinical judgement in the diagnosis of heart failure: a bayesian analysis from the BNP multinational study

    Article • Journal of the American College of Cardiology, March 2002, Elsevier

    Professor Philippe Gabriel STEG

  321. Primary results of the BNP multinational study: B-type natriuretic peptide in the emergency diagnosis of heart failure

    Article • Journal of the American College of Cardiology, March 2002, Elsevier

    Professor Philippe Gabriel STEG

  322. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms

    Article • Journal of the American College of Cardiology, March 2001, Elsevier

    Professor Philippe Gabriel STEG

  323. Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris

    Article • The American Journal of Cardiology, March 2001, Elsevier

    Professor Philippe Gabriel STEG

  324. A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction

    Article • International Journal of Cardiology, February 2001, Elsevier

    Professor Philippe Gabriel STEG

  325. Chronic radiodermatitis after cardiac catheterization

    Article • Catheterization and Cardiovascular Interventions, January 2001, Wiley

    Professor Philippe Gabriel STEG

  326. Myocardial infarction after aspirin cessation in stable coronary artery disease patients

    Article • International Journal of Cardiology, November 2000, Elsevier

    Professor Philippe Gabriel STEG

  327. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction

    Article • Journal of the American College of Cardiology, June 2000, Elsevier

    Professor Philippe Gabriel STEG

  328. Reperfusion syndrome: relationship of coronary blood flow reserve to left ventricular function and infarct size

    Article • Journal of the American College of Cardiology, April 2000, Elsevier

    Professor Philippe Gabriel STEG

  329. Aspirine et prévention du risque cardiovasculaire

    Article • La Revue de Médecine Interne, March 2000, Elsevier

    Professor Philippe Gabriel STEG

  330. Nouvelles approches en cardiologie interventionnelle.

    Article • médecine/sciences, January 2000, INIST-CNRS

    Professor Philippe Gabriel STEG

  331. Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience)

    Article • The American Journal of Cardiology, June 1999, Elsevier

    Professor Philippe Gabriel STEG

  332. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina

    Article • American Heart Journal, May 1999, Elsevier

    Professor Philippe Gabriel STEG

  333. NC100100, a new echo contrast agent for the assessment of myocardial perfusion—safety and comparison with technetium‐99m sestamibi single‐photon emission computed tomography in a randomized multicenter study

    Article • Clinical Cardiology, April 1999, Wiley

    Professor Philippe Gabriel STEG

  334. Rest reverse redistribution in acute reperfused myocardial infarction: Significance of post-injection Tl-SPECT images

    Article • Journal of Nuclear Cardiology, January 1999, Elsevier

    Professor Philippe Gabriel STEG

  335. Comparison of the prognostic value of C-Reactive protein and troponin I in patients with unstable angina pectoris

    Article • The American Journal of Cardiology, October 1998, Elsevier

    Professor Philippe Gabriel STEG

  336. Incidence, consequences, and risk factors of early reocclusion after primary and/or rescue percutaneous transluminal coronary angioplasty for acute myocardial infarction

    Article • The American Journal of Cardiology, September 1998, Elsevier

    Professor Philippe Gabriel STEG

  337. Hospital outcome after bailout coronary stenting in patients with acute myocardial infarction

    Article • Catheterization and Cardiovascular Diagnosis, August 1998, Wiley

    Professor Philippe Gabriel STEG

  338. A critical analysis of the concept of silent myocardial ischaemia

    Article • Nephrology Dialysis Transplantation, May 1998, Oxford University Press (OUP)

    Professor Philippe Gabriel STEG

  339. S31 The clinical promise of clopidogrel

    Article • Atherosclerosis, March 1998, Elsevier

    Professor Philippe Gabriel STEG

  340. Arterial response to mild balloon injury in the normal rabbit

    Article • Coronary Artery Disease, January 1998, Wolters Kluwer Health

    Professor Philippe Gabriel STEG

  341. Revascularization of Patients With Unstable Coronary Artery Disease

    Article • The American Journal of Cardiology, September 1997, Elsevier

    Professor Philippe Gabriel STEG

  342. Conservative management of patients with acute myocardial infarction and spontaneous acute patency of the infarct-related artery

    Article • American Heart Journal, August 1997, Elsevier

    Professor Philippe Gabriel STEG

  343. Are the Results of Primary Percutaneous Transluminal Coronary Angioplasty for Acute Myocardial Infarction Different During the “Off” Hours?

    Article • The American Journal of Cardiology, June 1997, Elsevier

    Professor Philippe Gabriel STEG

  344. Myocardial contrast echocardiography to assess spontaneous reperfusion during myocardial infarction

    Article • The Lancet, March 1997, Elsevier

    Professor Philippe Gabriel STEG

  345. Radial access for primary PTCA in patients with acute myocardial infarction and contraindication to or impossible femoral access

    Article • Catheterization and Cardiovascular Diagnosis, December 1996, Wiley

    Professor Philippe Gabriel STEG

  346. Decreased prevalence of late potentials with mechanical versus thrombolysis-induced reperfusion in acute myocardial infarction

    Article • Journal of the American College of Cardiology, May 1996, Elsevier

    Professor Philippe Gabriel STEG

  347. Perspectives de thérapie génique de la resténose

    Article • médecine/sciences, January 1996, INIST-CNRS

    Professor Philippe Gabriel STEG

  348. Nonlimited exercise test combined with high-dose dipyridamole for thallium-201 myocardial single-photon emission computed tomography in coronary artery disease

    Article • The American Journal of Cardiology, October 1995, Elsevier

    Professor Philippe Gabriel STEG

  349. Comparison using dynamic vectorcardiography and MIBI SPECT of ST-segment changes and myocardial MIBI uptake during percutaneous transluminal coronary angioplasty of the left anterior descending coronary artery

    Article • The American Journal of Cardiology, May 1995, Elsevier

    Professor Philippe Gabriel STEG

  350. 901-18 Naroparcil, a β-D Xyloside Analog, Limits Intimal Hyperplasia After Arterial Injury

    Article • Journal of the American College of Cardiology, February 1995, Elsevier

    Professor Philippe Gabriel STEG

  351. 957-108 Does Reperfusion Induced by Angioplasty Confer the Same Benefit as Thrombolysis in Terms of Late Potentials?

    Article • Journal of the American College of Cardiology, February 1995, Elsevier

    Professor Philippe Gabriel STEG

  352. Prevention of restenosis after coronary angioplasty: towards a molecular approach?

    Article • Fundamental and Clinical Pharmacology, January 1995, Wiley

    Professor Philippe Gabriel STEG

  353. Modulation of the Expression of the Granulocyte Adhesion Molecule, CR3, by Percutaneous Transluminal Coronary Angioplasty and Contrast Media

    Article • Investigative Radiology, March 1994, Wolters Kluwer Health

    Professor Philippe Gabriel STEG

  354. Late thrombotic obstruction of an aortic bioprosthetic valve: Successful treatment by oral anticoagulation

    Article • Clinical Cardiology, February 1993, Wiley

    Professor Philippe Gabriel STEG

  355. Utilization of Laser Arterial Angioplasty

    Article • Annals of Vascular Surgery, January 1989, Elsevier

    Professor Philippe Gabriel STEG

  356. Acute Left Ventricular Dysfunction during Unsuccessful Weaning from Mechanical Ventilation

    Article • Anesthesiology, August 1988, Wolters Kluwer Health

    Professor Philippe Gabriel STEG

  357. Percutaneous, in vivo excimer laser angioplasty: Results in two experimental animal models

    Article • Lasers in Surgery and Medicine, January 1988, Wiley

    Professor Philippe Gabriel STEG

  358. Arterial Gene Transfer

    Article • Springer Science + Business Media

    Professor Philippe Gabriel STEG